Systematic Review on Customized and Non-customized Device Techniques for the Endovascular Repair of the Aortic Arch

医学 主动脉弓 主动脉修补术 死亡率 外科 动脉瘤 主动脉
作者
Petroula Nana,Κωνσταντίνος Σπανός,Konstantinos Dakis,Athanasios D. Giannoukas,Tilo Kölbel,Stéphan Haulon
出处
期刊:Journal of Endovascular Therapy [SAGE]
卷期号:31 (4): 505-521 被引量:17
标识
DOI:10.1177/15266028221133701
摘要

Purpose: Open repair remains the standard of care for aortic arch pathologies. However, endovascular management became an attractive alternative for high-risk patients. This study aimed to assess the outcomes of the available endovascular techniques for aortic arch pathology management. Materials and Methods: A search of the English literature (2000–2022) using PubMed, EMBASE, via Ovid, and CENTRAL databases (February 1, 2022) was performed according to Preferred Reporting Items for Systematic Reviews and Meta-Analysis guidelines. Studies reporting on patients with aortic arch pathologies managed with custom-made devices ([CMDs] fenestrated or branched thoracic endovascular aortic repair [F/BTEVAR]) and non-CMDs (parallel graft or surgeon-modified FTEVAR) were eligible. Studies reporting on hybrid or open repair were excluded. Studies’ quality was assessed using the Newcastle-Ottawa Scale. Primary outcomes were technical success, 30 day mortality, and cerebrovascular events (CVEs). Secondary outcomes were re-intervention and mortality during follow-up. Results: Thirty studies (2135 patients) were included. Treatment indications were mainly dissections (652 cases [48.0%, 652/1358]; 90 type A, 506 type B; 364 acute, 163 chronic) and aneurysms (46.9%, 582/1239). Five studies (211 patients) reported on FTEVAR and 10 (388 patients) on BTEVAR. For FTEVAR, technical success rate was 98.3%. Thirty-day mortality was 3.8% and CVE rate was 12.3%. Ten deaths (9.7%) and 19 re-interventions (9%) were recorded during follow-up (24 months). Regarding BTEVAR, technical success rate was 98.7%, and 30 day mortality and CVE rates were 5.4% and 11.0%, respectively. During follow-up (27 months), 64 deaths (18.7%) and 33 re-interventions (9.6%) were recorded. Parallel graft technique was reported in 11 studies (901 patients). Technical success rate was 76.4%. Thirty-day mortality was 3.9% and 32 (4.3%) CVEs were recorded. Thirty-five deaths (4.4%) and 43 re-interventions (5.5%) were reported during follow-up (27 months). Surgeon-modified FTEVAR was described in 5 studies (635 patients). Technical success rate was 91.6%. At 30 days, 15 deaths (2.3%) and 22 CVEs (3.5%) were recorded. During follow-up (19 months), 26 deaths (4.2%) and 21 re-interventions (3.6%) were detected. Conclusions: Endovascular arch repair presented a variable technical success; >95% for F/BTEVAR; ≤90% for non-CMDs. Acceptable 30 day mortality rates were reported. Cerebrovascular event rates ranged up to 10%. These findings, adjacent to the estimated midterm mortality and re-interventions, set the need for further improvement. Clinical Impact Endovascular arch repair gains popularity as a valuable alternative, especially in patients considered unfit for open repair. According the available literature, any endovascular technique, including custom-made or off-the-shelf solutions, may be applied successfully, with acceptable early mortality. However, the perio-operative cerebrovascular event rate is still an issue, indicating the need for further advancements.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
苏玖染发布了新的文献求助10
刚刚
紧张的梦岚完成签到 ,获得积分10
1秒前
1秒前
欢呼如柏发布了新的文献求助10
1秒前
干净的小馒头完成签到 ,获得积分10
1秒前
影子完成签到 ,获得积分10
1秒前
2秒前
2秒前
3秒前
5秒前
Roypeng完成签到,获得积分10
5秒前
科研通AI2S应助skyler采纳,获得10
5秒前
zhlh完成签到,获得积分10
6秒前
调研昵称发布了新的文献求助10
7秒前
斯文墨镜完成签到,获得积分10
7秒前
8秒前
李健的小迷弟应助一丁雨采纳,获得10
8秒前
9秒前
wmm发布了新的文献求助10
10秒前
科研通AI2S应助as采纳,获得10
10秒前
11秒前
fffffffq完成签到,获得积分10
11秒前
动听牛排应助王sir采纳,获得20
12秒前
12秒前
小安完成签到,获得积分10
13秒前
充电宝应助王十采纳,获得10
13秒前
13秒前
13秒前
搁浅发布了新的文献求助30
14秒前
酷炫煎饼完成签到,获得积分10
15秒前
15秒前
思源应助123采纳,获得10
15秒前
16秒前
贪玩路灯发布了新的文献求助10
17秒前
lzm10010完成签到,获得积分10
17秒前
啊哈完成签到,获得积分10
17秒前
Ijaz完成签到,获得积分10
18秒前
涂山路完成签到 ,获得积分20
19秒前
小蘑菇应助xxxx采纳,获得10
19秒前
22秒前
高分求助中
The late Devonian Standard Conodont Zonation 2000
The Lali Section: An Excellent Reference Section for Upper - Devonian in South China 1500
Nickel superalloy market size, share, growth, trends, and forecast 2023-2030 1000
Smart but Scattered: The Revolutionary Executive Skills Approach to Helping Kids Reach Their Potential (第二版) 1000
Mantiden: Faszinierende Lauerjäger Faszinierende Lauerjäger 800
PraxisRatgeber: Mantiden: Faszinierende Lauerjäger 800
A new species of Coccus (Homoptera: Coccoidea) from Malawi 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3245645
求助须知:如何正确求助?哪些是违规求助? 2889398
关于积分的说明 8257916
捐赠科研通 2557696
什么是DOI,文献DOI怎么找? 1386434
科研通“疑难数据库(出版商)”最低求助积分说明 650327
邀请新用户注册赠送积分活动 626641